Sidra Medicine to host Qatar’s First Engineered Immune Cells in Cancer Immunotherapy Workshop


Qatar Foundation institution aims to make engineered immune cell therapy accessible for all cancer patients in Qatar

Doha, Qatar, 4 February 2019: Sidra Medicine will host Qatar’s first “Engineered Immune Cells in Cancer Immunotherapy” (EICCI) workshop from 15 to 16 February 2019.

The workshop theme From Discovery to Off-the-shelf development is aimed at bringing the rapidly evolving field of immune cell-based cancer therapies to the forefront in Qatar and making them accessible to pediatric and adult cancer patients in the country.

Dr. Cristina Maccalli, Staff Scientist at Sidra Medicine and EICCI workshop’s Chair said: “We are looking forward to welcoming some of the leading experts in this field to Qatar and to Sidra Medicine. It is the right platform for us to share case studies, best practice methodologies and knowledge that will ultimately benefit collaboration and patient care in the field of cell-based cancer immunotherapy.”

EICCI will bring together local and worldwide experts in immunology, oncology, hematology, gene and cell therapy while unveiling breakthrough clinical successes and technologies to help implement the efficacy and manufacturing of cell therapies.

“As an academic medical center, Sidra Medicine, is prioritizing several research programs that will help us embark on the path to personalized and precision medicine. We are currently developing immune cell-based cancer therapies for our pediatric cancer patients as a matter of research priority, whereby we would look to reprogram a patient’s immune cells to fight the cancer cells in their body. We are also hopeful it will also contribute to achieve the unmet need of providing innovative and highly efficacious treatments to patients affected with advanced neoplastic diseases in Qatar and in the MENA region,” Dr. Maccalli continued.

The EICCI workshop is a collaboration between Sidra Medicine and the National Center for Cancer Care and Research - Hamad Medical Corporation and the Qatar Cancer Society. This event has been awarded a sponsorship under the Conference Workshop Sponsorship Program -15th Cycle by the Qatar National Research Fund.

Engineered Immune Cells in Cancer Immunotherapy: from Discovery to Off-the-Shelf Development” will be held for two days from 15 to 16 February 2019 at the Auditorium in Sidra Medicine. To register and for details please visit

Sidra Medicine is also hosting a pre-workshop on Friday, 15 February 2019 which is an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners – Accreditation Department. It is approved for a maximum of 3.25 credits.

- END-

Download Arabic here